Oric Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q2 2024.
  • Oric Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -36.7 %, a 0.41% increase year-over-year.
  • Oric Pharmaceuticals, Inc. annual Return On Assets for 2023 was -38.6 %, a 10.3% decline from 2022.
  • Oric Pharmaceuticals, Inc. annual Return On Assets for 2022 was -35 %, a 29.3% decline from 2021.
  • Oric Pharmaceuticals, Inc. annual Return On Assets for 2021 was -27 %, a 28.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -36.7 +0.15 +0.41% Apr 1, 2024 Jun 30, 2024
Q1 2024 -34.8 +2.2 +5.94% Jan 1, 2024 Mar 31, 2024
Q4 2023 -38.6 -3.6 -10.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -35.9 -1.86 -5.47% Jul 1, 2023 Sep 30, 2023
Q2 2023 -36.9 -7.39 -25% Apr 1, 2023 Jun 30, 2023
Q1 2023 -37 -7.48 -25.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35 -7.93 -29.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34 -5.09 -17.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.5 +5.53 +15.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -29.5 +3.8 +11.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -27 +10.9 +28.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -28.9 +8.7 +23.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -35 Apr 1, 2021 Jun 30, 2021
Q1 2021 -33.3 Jan 1, 2021 Mar 31, 2021
Q4 2020 -37.9 Oct 1, 2020 Dec 31, 2020
Q3 2020 -37.6 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.